Target intelligence / Profile preview

Immunoglobulin heavy variable 7-56 (IGHV7-56)

Target
IGHV7-56
Molecular classification
Other (Immunoglobulin gene segment; Germline gene segment; Variable region gene)
01

Overview

Immunoglobulin heavy variable 7-56 (IGHV7-56) is described as a variable (V) gene segment in the immunoglobulin heavy chain (IGH) locus. These gene segments rearrange somatically in B cells to generate diverse immunoglobulin heavy chain variable regions, which are essential for the production of antibodies and the adaptive immune response[1][2][3]. The IGHV gene family displays extensive polymorphism and copy number variation, accounting for much of the diversity in the human antibody pool[1][2]. The functional roles and disease associations of specific IGHV segments (such as IGHV1-69, IGHV3-23, etc.) are well-documented; however, no reputable scientific references describe a segment labeled precisely as IGHV7-56. The IGHV locus is highly complex, and annotations may vary, but "IGHV7-56" does not appear in authoritative databases or literature, raising the possibility of a misnaming or non-standard nomenclature[2]. If specifically requesting information about antibody variable region genes as therapeutic targets, note that while their usage is a prognostic marker in diseases such as chronic lymphocytic leukemia, the segments themselves are not conventional drug targets[4].

Other names
7-56PIGHV756immunoglobulin heavy chain variable regionIGHV7-56
02

Biological functions

Antigen recognitionGeneration of antibody diversityAdaptive immune response
03

Disease associations

Other (No specific evidence links IGHV7-56 to disease, but variable region usage overall contributes to immune repertoire and can influence disease risk or antibody specificity in B-cell related disorders[4].)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 7-56 (IGHV7-56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 7-56 (IGHV7-56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call